GLP1R and myocardial infarction: The present study demonstrates that 11 weeks of GLP-1 or AC3174 infusion to post-MI rats developing CHF can significantly improve multiple clinically-relevant parameters of cardiac function in a model of moderate, stable, compensated heart failure.